104 related articles for article (PubMed ID: 7772523)
41. Shear stress-induced platelet aggregation in various types of von Willebrand disease.
Nakagawa-Nishimura Y; Sugimoto M; Tsuji S; Kuwahara M; Nishio K; Takahashi Y; Fujimura Y; Murata M; Handa M; Ikeda Y
Int J Hematol; 1995 Jun; 61(4):189-96. PubMed ID: 8547607
[TBL] [Abstract][Full Text] [Related]
42. Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complex.
Pareti FI; Mazzucato M; Bottini E; Mannucci PM
Br J Haematol; 1992 Sep; 82(1):81-6. PubMed ID: 1419806
[TBL] [Abstract][Full Text] [Related]
43. Antithrombotic Effects of Paeoniflorin from
Ngo T; Kim K; Bian Y; Noh H; Lim KM; Chung JH; Bae ON
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614534
[TBL] [Abstract][Full Text] [Related]
44. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
45. Porcine von Willebrand factor binding to human platelet GPIb induces transmembrane calcium influx.
Mazzucato M; De Marco L; Pradella P; Masotti A; Pareti FI
Thromb Haemost; 1996 Apr; 75(4):655-60. PubMed ID: 8743195
[TBL] [Abstract][Full Text] [Related]
46. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
[TBL] [Abstract][Full Text] [Related]
47. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.
Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R
Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169
[TBL] [Abstract][Full Text] [Related]
48. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
[TBL] [Abstract][Full Text] [Related]
49. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
[TBL] [Abstract][Full Text] [Related]
50. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
51. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
[TBL] [Abstract][Full Text] [Related]
52. Fine structural and functional consequences of deglycosylation of the platelet adhesion receptor GPIb-IX (CD 42b).
Moshfegh K; Lengweiler S; Häner M; Aebi U; Steiner B; Beer JH
Biochem Biophys Res Commun; 1998 Aug; 249(3):903-9. PubMed ID: 9731234
[TBL] [Abstract][Full Text] [Related]
53. Spontaneous platelet aggregation during pregnancy in a patient with von Willebrand disease type IIB can be blocked by monoclonal antibodies to both platelet glycoproteins Ib and IIb/IIIa.
Pareti FI; Federici AB; Cattaneo M; Mannucci PM
Br J Haematol; 1990 May; 75(1):86-91. PubMed ID: 2375928
[TBL] [Abstract][Full Text] [Related]
54. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
[TBL] [Abstract][Full Text] [Related]
55. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
56. Characterization of three alboaggregins purified from Trimeresurus albolabris venom.
Peng M; Lu W; Kirby EP
Thromb Haemost; 1992 Jun; 67(6):702-7. PubMed ID: 1509413
[TBL] [Abstract][Full Text] [Related]
57. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
[TBL] [Abstract][Full Text] [Related]
58. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
Gjønnaess E; Solum NO; Brosstad F
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
[TBL] [Abstract][Full Text] [Related]
59. Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate.
Goto S; Tamura N; Eto K; Ikeda Y; Handa S
Circulation; 2002 May; 105(21):2531-6. PubMed ID: 12034661
[TBL] [Abstract][Full Text] [Related]
60. A tetrameric glycoprotein Ib-binding protein, agglucetin, from Formosan pit viper: structure and interaction with human platelets.
Wang WJ; Ling QD; Liau MY; Huang TF
Thromb Haemost; 2003 Sep; 90(3):465-75. PubMed ID: 12958616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
